LabConnect to Expand its Tennessee Facility
The company plans to add 20,000 ft.2 to the site, tripling its clinical trial kit building capacity and further meeting the demand for cell and gene therapies, immuno-oncology, and other advanced therapeutics services.
LabConnect, a US-based provider of laboratory and support services for the biopharmaceutical industry, has expanded its facility in Johnson City, TN.
The company, which is known for its customized clinical trial collection kits, plans to add 20,000 ft.2 to the site, tripling its clinical trial kit building capacity and further meeting the demand for cell and gene therapies, immuno-oncology, and other advanced therapeutics services, LabConnect said in a March 16, 2021 press release.
“LabConnect’s expansion is a direct result of tremendous client response to our differentiated services and intense focus on quality and customer satisfaction,” said Tom Sellig, LabConnect’s CEO, in the press release. “The new facility, which will be operational in June, is being developed with funding from a continued partnership with the State of Tennessee. This new expansion comes after the recent expansion of LabConnect’s biorepository and sample storage facility completed in July of 2020.”
Source: LabConnect
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.
